FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,467,000 | -68.1% | 89,425 | -51.8% | 0.49% | -58.9% |
| Q4 2021 | $10,852,000 | -16.5% | 185,476 | -15.4% | 1.19% | +9.2% |
| Q3 2021 | $12,998,000 | -9.4% | 219,299 | +32.7% | 1.09% | +12.6% |
| Q2 2021 | $14,346,000 | +58.4% | 165,299 | +50.5% | 0.97% | +39.8% |
| Q1 2021 | $9,054,000 | +21.4% | 109,807 | +33.9% | 0.69% | +4.8% |
| Q4 2020 | $7,456,000 | -0.8% | 82,000 | -56.4% | 0.66% | -10.3% |
| Q3 2020 | $7,514,000 | -2.7% | 188,000 | -16.4% | 0.74% | +1.7% |
| Q2 2020 | $7,720,000 | – | 225,000 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |